On July 9, KPMG held the launch event of its "First Health and Elder Care 50" report and the awards ceremony in Shanghai. Leveraging its proprietary #Brain-Computer Interface (BCI) core technology and mature medical-eldercare implementation system, Hangzhou NEUREAL Technology Co., Ltd. was successfully selected for the list. Company Vice President Zhang Chuntang attended the event and participated in an industry roundtable forum, engaging in in-depth discussions on how neurotechnology empowers the silver economy.
China has entered a deeply aging society, with high prevalence of brain health issues among the elderly, including Mild Cognitive Impairment (MCI), post-stroke sequelae, geriatric depression, and sleep disorders. Traditional eldercare models have significant shortcomings: assessments rely on subjective scales and physician experience, making early identification of cognitive decline difficult; rehabilitation methods are limited, resulting in poor training compliance among the elderly; screening, intervention, and follow-up processes are fragmented, lacking dynamic personalized management. The KPMG report categorizes the eldercare industry into three segments: upstream eldercare technology products, midstream eldercare services, and downstream eldercare payments, identifying intelligent neurological rehabilitation devices as the core growth track of the industry.
In the roundtable forum, Zhang Chuntang stated: "The eldercare industry has long moved beyond basic life care; elderly brain health and cognitive function maintenance are critical pain points. Currently, the industry generally emphasizes care over brain rehabilitation and subjective judgment over quantitative standards. BCI technology can transform intangible neural activity into standardized objective data, connecting the entire process of 'early screening, early intervention, and long-term maintenance' to address the gap in neurological rehabilitation within integrated medical-eldercare systems."
He noted that the company's selection for the first Health and Elder Care 50 enterprise list recognizes the value of the non-invasive BCI digital eldercare sector and signifies that neurotechnology will become a key driver for the high-quality upgrade of the eldercare industry.
Unlike common resting-state EEG solutions in the industry, NEUREAL's core advantage lies inprecise neural signal elicitation technology, which centers on non-invasive EEG acquisition, using lightweight interactive scenarios only as auxiliary stimulation carriers. It actively activates neural networks related to memory, emotion, and attention to obtain highly stable, high-signal-to-noise ratio task-based EEG signals, solving industry challenges such as messy traditional BCI signals, modeling difficulties, and lack of assessment standards.
The company has established a closed-loop diagnostic and therapeutic system of "brain state recognition—targeted neuromodulation—real-time data feedback": devices simultaneously collect multimodal data including EEG, eye-tracking, and behavior. Relying on BCI-specific AI algorithms trained on tens of millions of clinical data points, it outputs objective cognitive assessment reports. The system dynamically adjusts intervention plans based on real-time EEG, synchronizing with neuromodulation modules for training, with clinical validation showing approximately 30% improvement in intervention efficacy. Supported by a complete product matrix, the solution covers diverse eldercare scenarios, building a full-cycle brain health management model of "hospital screening—institutional rehabilitation—home maintenance."
Experts at the scene unanimously agreed that digital healthcare technologies such as BCI can effectively extend healthy life expectancy for the elderly and serve as the core driving force for innovation in the eldercare industry. This listing marks a new beginning. NEUREAL will adhere to its mission of "improving human brain health through technology," continue to deepen its engagement in the all-age smart health and eldercare sector, protect elderly brain health through BCI innovation, and support the implementation of active aging and the Healthy China strategy.
As one of the Big Four global professional service firms, KPMG has been deeply engaged in China's healthcare industry for many years. With a comprehensive quantitative review system, cross-industry expert panels, and on-site visit mechanisms, its industry reports offer strong reference value and serve as authoritative bases for government, enterprises, and academia to assess the eldercare sector. The "First Health and Elder Care 50" report combines material reviews and on-site visits, covering the entire industrial chain of eldercare technology, services, and payments. Listed enterprises are benchmarks of comprehensive strength in their respective sub-sectors, and the list's prestige is widely recognized in the industry.
